TESORX Trademark

Trademark Overview

On Wednesday, February 5, 2020, a trademark application was filed for TESORX with the United States Patent and Trademark Office. The USPTO has given the TESORX trademark a serial number of 88785585. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 28, 2023. This trademark is owned by Tesorx Pharma, LLC. The TESORX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of hypogonadism in men with low testosterone
tesorx

General Information

Serial Number88785585
Word MarkTESORX
Filing DateWednesday, February 5, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 28, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 2, 2020

Trademark Statements

Description of MarkThe mark consists of the wording "TESORX" in stylized font whereby a curved line appears above the letter "O".
Goods and ServicesPharmaceutical preparations for the treatment of hypogonadism in men with low testosterone
Pseudo MarkTESO RX
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, February 8, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTesorx Pharma, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressMenlo Park, CA 94025
Party NameTesorx Pharma, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressMenlo Park, CA 94025

Trademark Events

Event DateEvent Description
Monday, August 28, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, August 28, 2023ABANDONMENT - NO USE STATEMENT FILED
Tuesday, January 10, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 9, 2023SOU EXTENSION 5 GRANTED
Friday, December 16, 2022SOU EXTENSION 5 FILED
Monday, January 9, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, December 16, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, July 26, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 22, 2022SOU EXTENSION 4 GRANTED
Friday, July 22, 2022SOU EXTENSION 4 FILED
Friday, July 22, 2022SOU TEAS EXTENSION RECEIVED
Friday, October 22, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 20, 2021SOU EXTENSION 3 GRANTED
Wednesday, October 20, 2021SOU EXTENSION 3 FILED
Wednesday, October 20, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, April 20, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 16, 2021SOU EXTENSION 2 GRANTED
Friday, April 16, 2021SOU EXTENSION 2 FILED
Friday, April 16, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, January 19, 2021ASSIGNED TO EXAMINER
Friday, January 8, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 6, 2021SOU EXTENSION 1 GRANTED
Wednesday, January 6, 2021SOU EXTENSION 1 FILED
Wednesday, January 6, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, July 28, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 2, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 2, 2020PUBLISHED FOR OPPOSITION
Wednesday, May 13, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, April 24, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, April 24, 2020ASSIGNED TO EXAMINER
Tuesday, February 11, 2020NOTICE OF DESIGN SEARCH CODE E-MAILED
Saturday, February 8, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, February 8, 2020NEW APPLICATION ENTERED

Related Keywords

tesorx testosterone hypogonadism treatment preparations pharmaceutical